CN1362068A - Rheumatoid disease treating capsule - Google Patents
Rheumatoid disease treating capsule Download PDFInfo
- Publication number
- CN1362068A CN1362068A CN00126789A CN00126789A CN1362068A CN 1362068 A CN1362068 A CN 1362068A CN 00126789 A CN00126789 A CN 00126789A CN 00126789 A CN00126789 A CN 00126789A CN 1362068 A CN1362068 A CN 1362068A
- Authority
- CN
- China
- Prior art keywords
- radix
- herba
- rhizoma
- partly
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 title abstract description 11
- 201000010099 disease Diseases 0.000 title abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 11
- 239000003814 drug Substances 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 11
- 241000208340 Araliaceae Species 0.000 claims abstract description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 5
- 241000522620 Scorpio Species 0.000 claims abstract description 5
- 235000008434 ginseng Nutrition 0.000 claims abstract description 5
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims description 7
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 241000271039 Agkistrodon Species 0.000 claims description 4
- 241000131329 Carabidae Species 0.000 claims description 4
- 239000009636 Huang Qi Substances 0.000 claims description 4
- 241000237636 Pheretima Species 0.000 claims description 4
- 241000131808 Scolopendra Species 0.000 claims description 4
- 241000255791 Bombyx Species 0.000 claims description 3
- 241000717739 Boswellia sacra Species 0.000 claims description 3
- 241000903946 Clematidis Species 0.000 claims description 3
- 241000628997 Flos Species 0.000 claims description 3
- 241001057584 Myrrha Species 0.000 claims description 3
- 241000180649 Panax notoginseng Species 0.000 claims description 3
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 3
- 241000222640 Polyporus Species 0.000 claims description 3
- 235000006463 Brassica alba Nutrition 0.000 claims description 2
- 244000140786 Brassica hirta Species 0.000 claims description 2
- 241000218671 Ephedra Species 0.000 claims description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 7
- 206010025135 lupus erythematosus Diseases 0.000 abstract description 5
- 239000009490 scorpio Substances 0.000 abstract description 3
- 210000001519 tissue Anatomy 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 230000036770 blood supply Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 230000004089 microcirculation Effects 0.000 abstract description 2
- 206010003246 arthritis Diseases 0.000 abstract 2
- 208000007442 rickets Diseases 0.000 abstract 2
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 241000233855 Orchidaceae Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000545405 Tripterygium Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 230000001172 regenerating effect Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010002027 Amyotrophy Diseases 0.000 description 1
- 208000008822 Ankylosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010061619 Deformity Diseases 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023198 Joint ankylosis Diseases 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000001618 algogenic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000078 anti-malarial effect Effects 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- -1 decoct secondary Substances 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 229960001929 meloxicam Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a medicine capsule for treating rheummoid arthritis and tetanic rachitis, which is prepared by using small dosage of tripterygium wilfordi as main material, 27 kinds of Chinese medicine such as ginseng, astragalus, monkshood, dried rhizome of rehmannia, nine-membered orchid extracted and boiled for a paste which is mixed with 14 kinds of Chinese medicine powder such as scorpio and centipede for the medicine capsule. It has been verified to improve microcirculation, increase the blood supply to backbone, juncture and tissue around them for more nutrition, enchance regenerating ability of tissue and cell activities for phologis absorption and reducing the pile of ache causing matter to cure disease both in principal and secondary asects by clinical test with ten thousands of samples in diseases of rheumanoid arthritis, tetanic rachitis, lupus erythematosus and drying syndrome.
Description
The present invention is a kind of Chinese patent medicine for the treatment of rheumatoid arthritis, ankylosing spondylitis, lupus erythematosus.
Rheumatoid arthritis, ankylosing spondylitis, all by the natural endowment deficiency, the day after tomorrow overstrain, intemperate sexual intercourse, it is multiple to lose blood puerperal, caused by liver and kidney deficiency, the affection of exogenous wind-cold damp, the resistance of QI and blood numbness becomes that to give birth to blood stasis expectorant turbid, stops up in stagnate joint, the ridge.Doctor and patient, in order to palliate the agonizing sufferings, the life-time service hormone has been covered the state of an illness, has affected treatment adversely, also produced the hormonelike blood stasis, made pathological changes local blood circulation obstacle, caused QI and blood unfavorable, muscles and bones mistake is supported, clonic spasm of the muscle bone pine, ankylosis, deformity, amyotrophy, paralysis is maimed.At present, adopt nonsteroidal antiinflammatory drug both at home and abroad, as: indometacin, ibuprofen, naproxen, diclofenac, meloxicam and golden preparation, antimalarial, methotrexate, the hormone medicine treatment, but eventually because of rheumatoid arthritis, ankylosing spondylitis, lupus erythematosus, disease is special, obstinate, cause the maimed paralysis of patient, become can be not dead cancer.
Purpose of the present invention is exactly in order to provide a kind of treatment rheumatoid arthritis, ankylosing spondylitis, the Chinese patent medicine capsule for rheumatoid disease of lupus erythematosus.
The object of the present invention is achieved like this, and capsule for rheumatoid disease is to be made by the following weight proportion raw material.
One, extracts partly
Make black river 15 Radix Aconiti Kusnezoffii Preparatas, 15 Rhizoma Arisaematis (processed), 15 Herba Asaris 15
Fructus Psoraleae 25 Radix Aconiti Lateralis Preparatas 25 Rhizoma Drynariae 25 Radix Astragali 100
Herba Epimedii 50 Radix Angelicae Sinensis 25 Radix Stephaniae Tetrandrae 50 Rhizoma Atractylodis Macrocephalaes 25
Radix Salviae Miltiorrhizae 50 Radix Rehmanniae 10 Radix Clematidis 50 Poria 25
Radix Gentianae Macrophyllae 25 Flos Lonicerae 25 Herba Aristolochiae Mollissimaes 25 Cortex Phellodendris 25
Polyporus 25 Herba Pileae Scriptaes 120 Herba Ephedraes 10 crust halberds 25
Rhizoma Curculiginis 25 Cortex Cinnamomis 5 Semen Sinapis Albaes 10
Two, fines is partly:
System Pheretima 15 Olibanums 10 Myrrhas 10 Agkistrodons 10
Nidus Vespae 15 Scorpios 15 Bombyx Batryticatus 15 Zaocyss 15
Ground beetle 15 Scolopendras 10 Radix Notoginseng 10 Radix Ginsengs 25
Semen Strychni (processed) powder 150 Radix Tripterygii Wilfordii extractum (0.1%) 6.
Capsule for rheumatoid disease prescription of the present invention, be with liver and kidney tonifying, cooperate dredge the meridian passage, improve immunologic function, search the product that pick heavy cold arthralgia due to blood stasis, rule together to scheme specimen, reuse Radix Ginseng, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis in the side, benefiting qi and nourishing blood is regulated immunologic function, Fructus Psoraleae, Rhizoma Drynariae, crust halberd, Rhizoma Curculiginis, Radix Aconiti Lateralis Preparata, Cortex Cinnamomi, Herba Epimedii, nourishing the liver and kidney, warming the meridian is supporing yang with cold expelling, insects medicines such as Semen Sinapis Albae, Rhizoma Arisaematis, ground beetle, Scorpio, Scolopendra, Pheretima, Radix Aconiti Kusnezoffii, Agkistrodon, search and pick the meridians expectorant stasis of blood, the priming sick institute that goes directly; Radix Aconiti Preparata, Herba Ephedrae, Radix Stephaniae Tetrandrae, Herba Asari, Radix Gentianae Macrophyllae, the wind dispelling collateral dredging, the damp eliminating reducing swelling and alleviating pain, Radix Tripterygii Wilfordii has multiple pharmacological effect such as significant antiinflammatory, immunosuppressant, the treatment rheumatoid arthritis, curative effect is sure, but side effect is outstanding, the present invention adopt low dose of Radix Tripterygii Wilfordii extractum (for usual amounts 1/6) be principal agent, obviously lowered poison and paid effect.All medicines share, and microcirculation improvement is promoted the blood supply of spinal column, joint and surrounding tissue thereof, improves nutritional status, quickens tissue regeneration ability and cell viability, promote spinal column, joint and inflammation absorption on every side thereof, algogenic substance is piled up reduced.Thereby remove rheumatoid, the stiff pain of ankylosing spondylitis symptom, promote functional rehabilitation.Be mainly used in rheumatoid arthritis, ankylosing spondylitis, the treatment of lupus erythematosus, our determined curative effect, the safety effect of paying is lacked.Through clinical verification, patient more than 98% is eliminated or palliate the agonizing sufferings.
Embodiments of the invention are described in detail in detail below.
1. the prescription of capsule for rheumatoid disease was specially by two most compositions:
One, extracts partly
Make black river 15g Radix Aconiti Kusnezoffii Preparata 15g Rhizoma Arisaematis (processed) 15g Herba Asari 15g
Fructus Psoraleae 25g Radix Aconiti Lateralis Preparata 25g Rhizoma Drynariae 25g Radix Astragali 100g
Herba Epimedii 50g Radix Angelicae Sinensis 25g Radix Stephaniae Tetrandrae 50g Rhizoma Atractylodis Macrocephalae 25g
Radix Salviae Miltiorrhizae 50g Radix Rehmanniae 10g Radix Clematidis 50g volt Siberian cocklebur 25g
Radix Gentianae Macrophyllae 25g Flos Lonicerae 25g Herba Aristolochiae Mollissimae 25g Cortex Phellodendri 25g
Polyporus 25g Herba Pileae Scriptae 120g Herba Ephedrae 10g crust halberd 25g
Rhizoma Curculiginis 25g Cortex Cinnamomi 5g Semen Sinapis Albae 10g
Two, fines is partly:
System Pheretima 15g Olibanum 10g Myrrha 10g Agkistrodon 10g
Nidus Vespae 15g Scorpio 15g Bombyx Batryticatus 15g Zaocys 15g
Ground beetle 15g Scolopendra 10g Radix Notoginseng 10g Radix Ginseng 25g
Semen Strychni (processed) powder 150 Radix Tripterygii Wilfordii extractum (0.1%) 6g.
2. the preparation method of capsule for rheumatoid disease:
(1) Semen Strychni (processed) powder: after getting qualified Semen Strychni and soaking 7 days with urine of baby boys, stir-baking with sand to color is sepia, pulverizes, and sieves, and is standby.
(2) preparation of Radix Tripterygii Wilfordii extractum: with Radix Tripterygii Wilfordii concoct qualified after, place decoction pot, add water and cross powder, decoct secondary, collecting decoction filters, and is condensed into cream, it is that 1.30,80 ℃ of crushed after being dried are sieved that heat is surveyed density (d), standby.
(3) preparation fines part medicated powder: the fines that infusion is qualified medical material partly, pulverize, sieve, standby.
(4) medicated powder is partly extracted in preparation: will extract medicinal material processing partly qualified after, place decoction pot, add water and cross powder, decoct secondary, liquid before merging filters, and is condensed into cream, heat survey density (d) is that 1.30,80 ℃ of crushed after being dried are sieved, and is standby.
(5) mix: will extract medicated powder partly, abundant mixing, fines medicated powder partly, the method that increases progressively by equivalent adds, and after sieving, incapsulates promptly.
Every capsules medicine weighs 0.3 soil 5%, by the capsule for rheumatoid disease that above amount is made, can obey three months, and three months is a course of treatment.Two weeks has promptly got tangible curative effect.Usage and dosage is one day three times, each 2～3, promptly obeys after meal.
Claims (1)
1. rheumatoid medicine for the treatment of rheumatoid arthritis, ankylosing spondylitis, it is characterized in that: it is made by the following weight proportion raw material, and it is partly formed by two:
One, extracts partly
Make black river 15 Radix Aconiti Kusnezoffii Preparatas, 15 Rhizoma Arisaematis (processed), 15 Herba Asaris 15
Fructus Psoraleae 25 Radix Aconiti Lateralis Preparatas 25 Rhizoma Drynariae 25 Radix Astragali 100
Herba Epimedii 50 Radix Angelicae Sinensis 25 Radix Stephaniae Tetrandrae 50 Rhizoma Atractylodis Macrocephalaes 25
Radix Salviae Miltiorrhizae 50 Radix Rehmanniae 10 Radix Clematidis 50 Poria 25
Radix Gentianae Macrophyllae 25 Flos Lonicerae 25 Herba Aristolochiae Mollissimaes 25 Cortex Phellodendris 25
Polyporus 25 Herba Pileae Scriptaes 120 Herba Ephedraes 10 crust halberds 25
Rhizoma Curculiginis 25 Cortex Cinnamomis 5 Semen Sinapis Albaes 10
Two, fines is partly:
System Pheretima 15 Olibanums 10 Myrrhas 10 Agkistrodons 10
Nidus Vespae 15 Scorpios 15 Bombyx Batryticatus 15 Zaocyss 15
Ground beetle 15 Scolopendras 10 Radix Notoginseng 10 Radix Ginsengs 25
Semen Strychni (processed) powder 150 Radix Tripterygii Wilfordii extractum (0.1%) 6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001267892A CN1193775C (en) | 2000-12-30 | 2000-12-30 | Rheumatoid disease treating capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001267892A CN1193775C (en) | 2000-12-30 | 2000-12-30 | Rheumatoid disease treating capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1362068A true CN1362068A (en) | 2002-08-07 |
| CN1193775C CN1193775C (en) | 2005-03-23 |
Family
ID=4592072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB001267892A Expired - Lifetime CN1193775C (en) | 2000-12-30 | 2000-12-30 | Rheumatoid disease treating capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1193775C (en) |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1300176C (en) * | 2005-06-29 | 2007-02-14 | 中国药科大学 | New saponin and its derivative, its preparation method and its use in medicine |
| CN1308020C (en) * | 2004-12-13 | 2007-04-04 | 刘文奇 | Traditional Chinese medicine composition for treating psoriasis |
| CN1330328C (en) * | 2005-06-29 | 2007-08-08 | 中国药科大学 | Extractive of total saponin of clematis root, prepn. method and pharmaceutical use thereof |
| CN1330354C (en) * | 2004-01-05 | 2007-08-08 | 刘少华 | A kind of traditional Chinese medicine composition for treating rheumatoid arthritis |
| CN100457137C (en) * | 2004-03-05 | 2009-02-04 | 广东药学院 | Polylactic acid microglobule Chinese medicine compound for mula used for treating bone arthritis and its preparation method |
| CN101301394B (en) * | 2008-06-27 | 2011-01-26 | 樊玉仁 | Medicament for treating rheumatoid disease |
| CN101485747B (en) * | 2009-03-04 | 2011-07-27 | 陈新华 | Chinese medicinal composition for treating degenerative pathologic changes of knee joint |
| CN102488818A (en) * | 2011-12-30 | 2012-06-13 | 伍启友 | Pharmaceutical composition for treating rheumatism and rheumatoid arthritis |
| CN101502571B (en) * | 2009-03-16 | 2012-07-04 | 上海师范大学 | Blood circulation-promoting, antalgic and anti-inflammatory medicament as well as preparation method and use thereof |
| CN102600404A (en) * | 2012-03-28 | 2012-07-25 | 裴晶 | Traditional Chinese medicine for treating undifferentiated spondyloarthropathy |
| CN102716252A (en) * | 2011-06-20 | 2012-10-10 | 王长锋 | Medicine for oral use for treating rheumatism and rheumatoid ankylosing spondylitis |
| CN102872387A (en) * | 2012-10-11 | 2013-01-16 | 王慧艳 | Traditional Chinese medicine composition for treating arthralgia caused by wind-damp-heat pathogens |
| CN102186489B (en) * | 2008-10-07 | 2013-10-02 | 特拉维夫大学拉玛特有限公司 | Use of cinnamon bark extract for treating amyloid-associated diseases |
| CN105687917A (en) * | 2016-04-25 | 2016-06-22 | 沙宗跃 | Oral solution for treating arthritis |
| CN109200156A (en) * | 2018-11-12 | 2019-01-15 | 徐扬 | A kind of traditional Chinese herbal decoction for treating deficiency of vital energy cold dampness accumulation pattern ankylosing spondylitis |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101015650B (en) * | 2006-12-04 | 2010-05-12 | 尹政德 | Zhuifeng Touguhuoluo pill (capsule) and its production process |
-
2000
- 2000-12-30 CN CNB001267892A patent/CN1193775C/en not_active Expired - Lifetime
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1330354C (en) * | 2004-01-05 | 2007-08-08 | 刘少华 | A kind of traditional Chinese medicine composition for treating rheumatoid arthritis |
| CN100457137C (en) * | 2004-03-05 | 2009-02-04 | 广东药学院 | Polylactic acid microglobule Chinese medicine compound for mula used for treating bone arthritis and its preparation method |
| CN1308020C (en) * | 2004-12-13 | 2007-04-04 | 刘文奇 | Traditional Chinese medicine composition for treating psoriasis |
| CN1300176C (en) * | 2005-06-29 | 2007-02-14 | 中国药科大学 | New saponin and its derivative, its preparation method and its use in medicine |
| CN1330328C (en) * | 2005-06-29 | 2007-08-08 | 中国药科大学 | Extractive of total saponin of clematis root, prepn. method and pharmaceutical use thereof |
| CN101301394B (en) * | 2008-06-27 | 2011-01-26 | 樊玉仁 | Medicament for treating rheumatoid disease |
| CN102186489B (en) * | 2008-10-07 | 2013-10-02 | 特拉维夫大学拉玛特有限公司 | Use of cinnamon bark extract for treating amyloid-associated diseases |
| CN101485747B (en) * | 2009-03-04 | 2011-07-27 | 陈新华 | Chinese medicinal composition for treating degenerative pathologic changes of knee joint |
| CN101502571B (en) * | 2009-03-16 | 2012-07-04 | 上海师范大学 | Blood circulation-promoting, antalgic and anti-inflammatory medicament as well as preparation method and use thereof |
| CN102716252A (en) * | 2011-06-20 | 2012-10-10 | 王长锋 | Medicine for oral use for treating rheumatism and rheumatoid ankylosing spondylitis |
| CN102716252B (en) * | 2011-06-20 | 2014-11-19 | 王长锋 | Medicine for oral use for treating rheumatism and rheumatoid ankylosing spondylitis |
| CN102488818B (en) * | 2011-12-30 | 2013-06-05 | 伍启友 | Pharmaceutical composition for treating rheumatism and rheumatoid arthritis |
| CN102488818A (en) * | 2011-12-30 | 2012-06-13 | 伍启友 | Pharmaceutical composition for treating rheumatism and rheumatoid arthritis |
| CN102600404A (en) * | 2012-03-28 | 2012-07-25 | 裴晶 | Traditional Chinese medicine for treating undifferentiated spondyloarthropathy |
| CN102600404B (en) * | 2012-03-28 | 2013-11-13 | 刘玉柱 | Traditional Chinese medicine for treating undifferentiated spondyloarthropathy |
| CN102872387A (en) * | 2012-10-11 | 2013-01-16 | 王慧艳 | Traditional Chinese medicine composition for treating arthralgia caused by wind-damp-heat pathogens |
| CN105687917A (en) * | 2016-04-25 | 2016-06-22 | 沙宗跃 | Oral solution for treating arthritis |
| CN109200156A (en) * | 2018-11-12 | 2019-01-15 | 徐扬 | A kind of traditional Chinese herbal decoction for treating deficiency of vital energy cold dampness accumulation pattern ankylosing spondylitis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1193775C (en) | 2005-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1186043C (en) | Exterior-applied medicine for treating osteopathy | |
| CN101632737B (en) | Medicament for relieving pain of human body and preparation method thereof | |
| CN1193775C (en) | Rheumatoid disease treating capsule | |
| CN1224614A (en) | Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation | |
| CN101987122A (en) | Medicament for easing pain of human body and preparation method thereof | |
| CN101085223A (en) | Medicine for treating rheumatism and rheumatoid disease | |
| CN1204523A (en) | Prescription of dispelling wind and strengthening bone wine and preparation method | |
| CN1278446A (en) | Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease | |
| CN101066303A (en) | Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its prepn | |
| CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
| CN101690768B (en) | Vein and artery relieving pills for impediment of sinew | |
| CN102657736B (en) | Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition | |
| CN1683001A (en) | Chinese medicine for treating gout | |
| CN1082376C (en) | Pathogenic factor eliminating and healthy energy supporting anticancer medicine | |
| CN1079029C (en) | Medical capsule for treating bone rheumatism and preparing process | |
| CN101317958B (en) | Medicament for treating uarthritis, that is Tongfengning capsule and preparation method thereof | |
| CN1180821C (en) | Medicine for treating cerebral thrombus and its prepn | |
| CN1745795A (en) | Medicine for preventing and treating coronary heart disease and preparation method thereof | |
| CN101264187A (en) | Medicinal composition for treating chronic prostatitis and prostatic hyperplasia | |
| CN108310217A (en) | Zhuanggu medicinal liquor and production method | |
| CN106344680B (en) | A kind of Chinese medicine composition with wind and relieving paralysis effect of dispelling and preparation method thereof | |
| CN1054986C (en) | Chinese medicine pill for treating rheumatoid disease | |
| CN1249191A (en) | Powdered medicine for treating vasculitis and its preparing process | |
| CN1235605C (en) | Medicinal composition for treating gall | |
| CN102743531B (en) | Drug for treating cervical or lumbar diseases and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20050323 |
|
| CX01 | Expiry of patent term | ||
| DD01 | Delivery of document by public notice |
Addressee: Li Yi Document name: Notice of expiration of patent right |
|
| DD01 | Delivery of document by public notice |